БАЗА МЕДИЦИНСКИХ ЗНАНИЙ

Summary of National Advisory Committee on Immunization (NACI) Statement of February 2023: Public Health Level Recommendations on the Use of Pneumococcal Vaccines in Adults, Including the Use of 15-Valent and 20-Valent Conjugate Vaccines

National Advisory Committee on ImmunizationВакцинация2023Официальная публикация

Документальный обзор ASEM

Official National Advisory Committee on Immunization document (2023) on “Summary of National Advisory Committee on Immunization (NACI) Statement of February 2023: Public Health Level Recommendations on the Use of Pneumococcal Vaccines in Adults, Including the Use of 15-Valent and 20-Valent Conjugate Vaccines”. Use of conjugate pneumococcal vaccine – 15 valent (PNEU-C-15) and 20 valent (PNEU-C-20) in adults: Summary of NACI Statement of February 2023.

Это краткое содержание помогает найти нужный документ. В отношении клинических рекомендаций всегда сверяйтесь с официальной версией и датой её обновления.

Официальный документ

По той же теме

Summary of NACI statement of May 2026: Statement on seasonal influenza vaccines for 2026-2027 Summary of NACI statement of June 2026: Guidance on the use of COVID-19 vaccines starting fall 2026 Summary of updates in the Canadian Immunization Guide as of March 31, 2025: Updated guidance on quadrivalent conjugate meningococcal vaccines available in Canada